Skip to main content

Table 3 Dosimetry Analysis: The percent of the planned target volume (PTV) or organ receiving 50, 95, 100, or 150% of the prescribed dose at depth followed by the maximum point dose in cGy to the indicated organ

From: Prospective multi-center trial utilizing electronic brachytherapy for the treatment of endometrial cancer

 

Mean % ± SD

Range

%V95

91.0 ± 13.6

49.0 - 103.0

%V100

87.6 ± 13.7

48.0 - 98.0

%V150

34.1 ± 15.6

3.3 - 69.7

Bladder %V50

11.5 ± 9.7

0 - 40.2

Rectal %V50

17.4 ± 10.9

0 - 36.0

Max Point Dose to Bladder

701.2 ± 169.3 cGy

467 - 1087 cGy

Max Point Dose to Rectum

775.0 ± 355.4 cGy

100 - 1584 cGy

Max Point Dose to Small Bowel

421.3 ± 391.1 cGy

0 - 1188 cGy